Former HPIC customers DJS Antibodies has just been acquired by AbbVie for $255 million
Congratulations to DJS Antibodies, a biotechnology company dedicated to creating the next generation of antibody therapeutics, who started life at HPIC using shared lab bench space and have just been acquired by AbbVie for $255 million. HPIC are currently asking bio tech start-ups to apply for the opportunity to secure […]